By proceeding, you agree to our Terms of Use and Privacy Policy.
Evaluating toxic response in the context of immunomodulatory treatments continues to challenge the drug development community. Measuring if novel therapeutics have the potential to evoke a critical toxic response in the clinic is extremely difficult.
Explore and discuss the most pressing challenges and gain a broader understanding of utilizing preclinical platforms in multiple disease indications.
Discover how you can utilize translationally relevant models to demonstrate the efficacy of your drug candidates.
Learn and connect with experts like Andrew Puca, Brian Soper, Greg Christianson, James G. Keck, Lauren Elolf and Michael Brehm.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.